Tianjin Pharmaceutical Group Technology Development

Tianjin Pharmaceutical Group Technology Development is the primary research and innovation subsidiary of the Tianjin Pharmaceutical Group (TPG), one of China's largest pharmaceutical conglomerates. The company focuses on the development of high-end chemical drugs, traditional Chinese medicines, and health products, with a particular global leadership in corticosteroid APIs and formulations. It manages the group's R&D lifecycle, including drug synthesis, formulation optimization, and generic consistency evaluation. The center plays a vital role in TPG's vertical integration strategy, supporting its expansion into international markets through advanced quality control and regulatory compliance. Its therapeutic focus spans cardiovascular health, endocrinology, and respiratory medicine.